Skip to main content
Clinical Trials/DRKS00000215
DRKS00000215
Recruiting
Not Applicable

Prospective study with the aim to investigate the biological relevance of fibrinolysis products and their use as prognostic and therapeutic biomarkers in SIRS and SEPSIS.

Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieKlinikum der J.W.-Goethe Universität0 sites150 target enrollmentAugust 23, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
A41.9
Sponsor
Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieKlinikum der J.W.-Goethe Universität
Enrollment
150
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 23, 2010
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieKlinikum der J.W.-Goethe Universität

Eligibility Criteria

Inclusion Criteria

  • Stay at ICU \>\=48h, positive consent, no active neoplasia (\>10 years)

Exclusion Criteria

  • active Neoplasia, age \<18 years, no consent

Outcomes

Primary Outcomes

Not specified

Similar Trials